We are looking for children 2 to 17 years of age to join a UC clinical research study to help us discover more about treating moderate to severe CD. If you are looking for a potential new treatment option for moderate to severe CD or moderately to severely active IBD (including associated symptoms such as abdominal pain, failure to thrive, constant need to poop, malnutrition and/or joint pain), consider one of our GI clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years of age may be eligible to take part.
Your child may be eligible to take part in the GI clinical research studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
See if your child qualifies.
